Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 14, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	374	465	157	29	35	62
Market Cap Growth	-15.54%	195.83%	434.24%	-16.81%	-42.59%	1.75%
Enterprise Value	359	468	159	27	31	61
Last Close Price	0.35	0.43	0.15	0.03	0.03	0.06
PE Ratio	9.75	-	7.81	8.26	3.97	12.10
PS Ratio	2.67	5.53	2.77	0.86	1.10	2.42
PB Ratio	4.66	8.68	2.73	1.01	1.40	3.81
P/TBV Ratio	4.68	8.73	2.74	1.03	1.43	3.92
P/FCF Ratio	21.71	79.70	-	-	5.88	21.50
P/OCF Ratio	20.21	62.33	-	8.81	5.43	19.27
EV/Sales Ratio	2.56	5.56	2.81	0.80	0.96	2.40
EV/EBITDA Ratio	6.66	20.43	13.09	5.25	4.94	17.86
EV/EBIT Ratio	6.95	22.05	14.75	6.92	6.11	28.90
EV/FCF Ratio	20.84	80.19	-	-	5.15	21.24
Debt / Equity Ratio	0.08	0.20	0.20	0.13	0.11	0.15
Debt / EBITDA Ratio	0.11	0.46	0.95	0.73	0.43	0.66
Debt / FCF Ratio	0.35	1.87	-	-	0.46	0.83
Net Debt / Equity Ratio	-0.19	-0.01	0.08	-0.14	-0.23	-0.05
Net Debt / EBITDA Ratio	-0.28	-0.02	0.38	-0.75	-0.92	-0.24
Net Debt / FCF Ratio	-0.87	-0.07	-1.14	1.65	-0.96	-0.28
Asset Turnover	1.29	0.93	0.91	0.90	1.05	0.99
Inventory Turnover	3.03	3.01	2.69	2.16	2.97	2.95
Quick Ratio	5.28	3.42	2.04	1.40	1.73	1.15
Current Ratio	7.34	4.88	3.07	2.75	2.82	2.10
Return on Equity (ROE)	74.36%	-7.77%	46.47%	13.15%	43.01%	37.96%
Return on Assets (ROA)	29.75%	14.72%	10.83%	6.52%	10.33%	5.14%
Return on Invested Capital (ROIC)	76.25%	36.77%	24.74%	15.95%	29.14%	14.57%
Return on Capital Employed (ROCE)	45.60%	25.10%	15.30%	12.00%	17.80%	10.30%
Earnings Yield	11.60%	-0.93%	12.80%	12.11%	25.18%	8.27%
FCF Yield	4.61%	1.26%	-2.57%	-8.15%	17.00%	4.65%
Buyback Yield / Dilution	-4.95%	-4.40%	-1.02%	-0.23%	-7.17%	5.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.